VRTX
Vertex Pharmaceuticals Inc
504.70$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.87 | 0.90 | 5.00 | -14.54 | 5.25 | 2.24 | 3.16 | 4.14 | 4.82 | 1.94 | 5.57 | 4.40 | 16.79 | |
| 0.16 | 0.23 | 0.20 | 0.21 | 0.20 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 | 0.22 | 0.22 | 0.87 | |
| 0.50 | 0.80 | 0.73 | 0.60 | 0.71 | 0.64 | 0.64 | 0.65 | 0.76 | 0.62 | 0.65 | 0.67 | 2.69 | |
| 0.72 | -3.22 | 0.50 | -0.94 | 0.60 | -2.15 | -1.03 | -0.51 | 0.58 | -3.70 | 0.95 | -0.45 | -2.61 | |
| 0.16 | 0.22 | 0.95 | 0.30 | 0.26 | 0.36 | 0.16 | 0.56 | 0.40 | 0.58 | 0.52 | 0.44 | 1.94 | |
| -0.45 | -3.40 | -8.18 | -1.80 | -1.33 | -3.16 | -0.22 | -1.87 | -0.45 | -1.12 | -1.69 | -0.18 | -3.45 | |
| 0.06 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.45 | -0.57 | -0.50 | -1.24 | -1.18 | -1.60 | -1.64 | -1.51 | -4.16 | -0.51 | -2.21 | -1.85 | -8.76 | |
| – | – | – | – | -0.02 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | – | – | – | |
| -0.63 | -0.46 | -1.37 | -1.39 | -1.48 | -1.50 | -2.62 | -1.35 | -4.48 | -0.30 | -2.10 | -1.67 | -8.59 | |
| 3.70 | -2.85 | -4.61 | -17.74 | 2.52 | -2.59 | 0.44 | 1.15 | -0.13 | 0.55 | 1.63 | 2.54 | 4.58 | |
| 4.71 | 0.68 | 4.05 | -14.84 | 4.99 | 1.89 | 3.00 | 3.58 | 4.42 | 1.36 | 5.05 | 3.96 | 14.85 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.